Semax Boosts Brain-Derived Neurotrophic Factor (BDNF) in the Hippocampus

The nootropic peptide Semax (ACTH 4-10 analog) increased BDNF and TrkB receptor expression in the rat hippocampus — providing a molecular mechanism for its cognitive-enhancing and neuroprotective effects.

Dolotov, Oleg V et al.·Brain research·2006·Moderate EvidenceAnimal StudyAnimal Study
RPEP-01129Animal StudyModerate Evidence2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Semax upregulated BDNF mRNA and TrkB receptor expression in the rat hippocampus, providing the neurotrophic molecular mechanism for its documented cognitive enhancement and neuroprotective effects — BDNF is the brain's primary growth and survival factor.

Key Numbers

How They Did This

animal-study study on semax, neuroprotection.

Why This Research Matters

Relevant for semax, neuroprotection, cognitive-enhancement.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Semax upregulated BDNF mRNA and TrkB receptor expression in the rat hippocampus, providing the neurotrophic molecular mechanism for its documented cog
Evidence Grade:
moderate evidence.
Study Age:
Published in 2006.
Original Title:
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.
Published In:
Brain research, 1117(1), 54-60 (2006)
Database ID:
RPEP-01129

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Semax Boosts Brain-Derived Neurotrophic Factor (BDNF) in the Hippocampus

What was found?

The nootropic peptide Semax (ACTH 4-10 analog) increased BDNF and TrkB receptor expression in the rat hippocampus — providing a molecular mechanism for its cognitive-enhancing and neuroprotective effects.

Read More on RethinkPeptides

Cite This Study

RPEP-01129·https://rethinkpeptides.com/research/RPEP-01129

APA

Dolotov, Oleg V; Karpenko, Ekaterina A; Inozemtseva, Lyudmila S; Seredenina, Tamara S; Levitskaya, Natalia G; Rozyczka, Joanna; Dubynina, Elena V; Novosadova, Ekaterina V; Andreeva, Lyudmila A; Alfeeva, Lyudmila Yu; Kamensky, Andrey A; Grivennikov, Igor A; Myasoedov, Nikolay F; Engele, Jürgen. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.. Brain research, 1117(1), 54-60.

MLA

Dolotov, Oleg V, et al. "Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.." Brain research, 2006.

RethinkPeptides

RethinkPeptides Research Database. "Semax, an analog of ACTH(4-10) with cognitive effects, regul..." RPEP-01129. Retrieved from https://rethinkpeptides.com/research/dolotov-2006-semax-an-analog-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.